Cervical cancer holds a heartbreaking distinction: it is one of the leading causes of cancer-related mortality among Nigerian women, yet it is almost entirely preventable.
Unlike many cancers where the direct cause is ambiguous or multifactorial, cervical cancer is directly linked to persistent infection with high-risk strains of the Human Papillomavirus (HPV). Because medical science understands the exact virus responsible, we have two powerful shields: vaccination to prevent the infection in the first place, and screening to detect and treat precancerous cell changes long before cancer develops.
Taking control of cervical health protects the daughters, mothers, and sisters of our communities from a needless battle.
Understanding the Culprit: What Is HPV?
Human Papillomavirus is an extremely common, sexually transmitted virus. Most sexually active adults will be exposed to HPV at some point in their lives. In the majority of people, the body’s immune system clears the virus naturally without causing harm or symptoms.
However, when a high-risk strain of HPV persists in the cervix over several years, it quietly alters normal cervical cells. Without medical detection, these abnormal cells can gradually progress into precancerous lesions and, over 10 to 15 years, develop into invasive cervical cancer.
The First Shield: The HPV Vaccine
The HPV vaccine protects against the specific high-risk types of the virus that cause up to 70–80% of all cervical cancers worldwide.
-
Who Should Receive It: The primary target group is adolescent girls aged 9 to 14 years, ideally before they become sexually active and exposed to the virus.
-
Catch-Up Dosing: Young women into their 20s can still benefit from the vaccine if they have not yet received it.
-
Safety and Efficacy: The HPV vaccine has been rigorously evaluated across global populations and within Nigeria’s national immunization frameworks. It does not cause infertility, disrupt menstrual cycles, or promote early sexual activity; it is simply a shield that equips young girls with antibodies to fight off cancer-causing infections later in life.
If you have an eligible daughter, niece, or younger sister, prioritizing her HPV vaccination is one of the most proactive health investments you can make for her future.
The Second Shield: Regular Screenings
Vaccination prevents new infections, but routine screening protects women who may have already been exposed to the virus. Cervical screening catches cellular changes while they are still precancerous, meaning they can be quickly removed or treated in an outpatient clinic before turning malignant.
Nigerian women aged 25 to 65 should prioritize one of the following screening methods:
1. Pap Smear (Cervical Cytology)
During a pelvic exam, a healthcare provider uses a small brush or spatula to gently collect a sample of cells from the surface of the cervix. The sample is sent to a pathology laboratory to check for abnormal or pre-malignant changes.
-
Frequency: Typically recommended every 3 years for women with normal results.
2. Visual Inspection with Acetic Acid (VIA)
Commonly utilized in community health clinics and secondary centers across Nigeria, VIA involves applying a diluted vinegar solution to the cervix. Any abnormal areas turn distinctively white, allowing the clinician to immediately identify problem tissue and often offer treatment on the spot (a “screen-and-treat” model).
-
Frequency: Recommended every 3 years in settings where laboratory cytology is unavailable.
3. High-Risk HPV DNA Testing
A sensitive molecular test that detects the presence of the actual DNA from high-risk HPV strains in cervical cells.
-
Frequency: When negative, this test provides reassurance for up to 5 years.
Symptoms That Require Urgent Attention
Cervical precancer and early-stage disease rarely produce pain or visible discomfort. That is why waiting for symptoms before checking is dangerous. If any of the following signs occur, consult a doctor immediately:
-
Unusual vaginal bleeding (between regular periods, after sexual intercourse, or after menopause)
-
Watery, foul-smelling, or blood-tinged vaginal discharge
-
Persistent pain during intercourse
-
Unexplained, chronic pain in the lower abdomen, pelvis, or lower back
Overcoming Fear and Misconceptions
Pelvic exams and reproductive health discussions are often treated with hesitation or shame in local communities. Some believe that attending a cervical check implies infidelity, or that a positive screening result means immediate tragedy.
These myths cost lives. An abnormal screening result does not mean you have full-blown cancer; it means your doctor has caught an issue at the exact stage where it can be cured simply and affordably.
At Hearts and Roses Cancer Advocacy Foundation, we bring age-appropriate education into schools, market associations, and faith-based groups across Owerri, Imo State. We advocate for accessible screenings, combat misinformation, and assist families in finding accredited clinics.
Talk to the women in your circle today about scheduling a screening or getting younger family members vaccinated. Prevention saves lives when we choose knowledge over silence.